News - Actelion, Financial

Filter

Current filters:

ActelionFinancial

Popular Filters

Actelion posts strong first-quarter 2014 results

Actelion posts strong first-quarter 2014 results

17-04-2014

Switzerland’s Actelion today announced financial results for the first three months of 2014, showing…

ActelionBiotechnologyFinancial

US Court upholds damages award in Actelion/Asahi litigation

14-03-2014

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalNorth AmericaRespiratory and PulmonaryUSA

Actelion 2013 sales and earnings beat expectations

Actelion 2013 sales and earnings beat expectations

11-02-2014

Switzerland-based Actelion, Europe’s largest biotech firm, has reported financial results for full-year…

ActelionBiotechnologyFinancial

Actelion’s PAH drugs boost 4% rise in sales

Actelion’s PAH drugs boost 4% rise in sales

17-10-2013

Actelion has announced its financial results for the first nine months of 2013 revealing product sales…

ActelionBiotechnologyCardio-vascularCeptaris TherapeuticsEuropeFinancialTracleerVeletriVentavisZavesca

Actelion posts healthy first-quarter 2013 results, forecasts double-digit growth in 2015

16-04-2013

Switzerland-based Actelion (SIX: ATLN), Europe's largest biotech firm, today (April 16) reported first-quarter…

ActelionBiotechnologyFinancial

Actelion posts strong earnings growth but flat sales for 2012

14-02-2013

Switzerland-based Actelion (SIX: ATLN), Europe's largest biotechnology firm, this morning reported 2012…

ActelionBiotechnologyFinancial

Actelion post sales dip for first nine months, but back in profit

18-10-2012

Switzerland's Actelion (SIX: ATLN) posted financial results for the first nine months of 2012, with product…

ActelionBiotechnologyFinancialmacitentanOpsumitResearchRespiratory and Pulmonaryselexipag

Swiss biotech Actelion implements cost saving initiative

11-09-2012

Switzerland-based Actelion (SIX: ATLN), Europe's largest biotech company, says that it has now concluded…

ActelionBiotechnologyFinancialManagement

Actelion hikes earnings outlook despite lower sales

20-07-2012

Switzerland-based Actelion (ATLN: VX), Europe's largest biotech company, reported first-half 2012 financial…

ActelionBiotechnologyFinancial

Actelion announces cost saving initiative; Ipsen to hang on to Dreux

12-07-2012

Europe largest biotech firm, Actelion (SIX: ATLN) this morning said it has launched a cost saving initiative…

ActelionBiotechnologyEuropeFinancialIpsenPharmaceutical

Actelion 1st-qtr profits slump as lead product sales slip

19-04-2012

Switzerland-based Actelion (ATLN: VX), Europe's largest biotech firm, posted first-quarter 2012 financial…

ActelionBiotechnologyFinancial

Legal provisions take toll on Actelion

14-02-2012

Switzerland-based Actelion (ATLN: VX), Europe’s largest biotech company, this morning posted full-year…

ActelionBiotechnologyFinancial

Actelion to appeal even though US court cuts original verdict by nearly $170 million in dispute with Asahi

21-11-2011

Despite a final judgement issued on Friday by the Superior Court of the State of California, USA, to…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalLicensing

Actelion granted motion for new trial in Asahi damages dispute

24-10-2011

Europe’s largest biotech company, Actelion (SIX: ATLN), announced this morning that, the Superior…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegal

Actelion posts 85.6 Swiss franc loss for first nine months of 2011

20-10-2011

Switzerland-based Actelion (ATLN: VX) recorded an operating loss of 85.6 million Swiss francs ($95.5…

ActelionBiotechnologyFinancial

Back to top